Biweekly paclitaxel plus gemcitabine in advanced breast cancer: phase II trial and predictive value of HER2 extracellular domain. (Q44754071)
Jump to navigation
Jump to search
scientific article published in February 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Biweekly paclitaxel plus gemcitabine in advanced breast cancer: phase II trial and predictive value of HER2 extracellular domain. |
scientific article published in February 2004 |
Statements
Biweekly paclitaxel plus gemcitabine in advanced breast cancer: phase II trial and predictive value of HER2 extracellular domain (English)
A Llombart-Cussac
A Barnadas
B Ojeda
V Carañana
Y Fernández
J García-Conde
S Alonso
S Montero
J Hornedo
1 February 2004